Mortality risk for kidney transplant candidates with diabetes: a population cohort study.

Aims/hypothesis: It is unclear whether kidney transplant candidates with diabetes have equitable transplantation opportunities or have divergent survival probabilities stratified by kidney replacement therapy. The aim of this study was to investigate these two issues using national transplant registry data in the UK.

Methods: A cohort study was undertaken of prospectively collected registry data of all wait-listed people with kidney failure receiving dialysis in the UK.

Contrast Induced Nephropathy In High Risk Patients - Myth Or Reality.

Background: Contrast induced nephropathy (CIN) is a potential stumbling block in administration of contrast media. CIN has been defined as an elevation of serum creatinine (sCr) of more than ≥0.5 mg/dl (44 μmol/l) or 25% from the baseline within 48-72 hours in the truancy of alternate tenets of acute kidney injury.

End-stage kidney disease patients from ethnic minorities and mortality in coronavirus disease 2019.

Introduction: Coronavirus disease 2019 (COVID-19) adversely affects patients who are older, multimorbid, and from Black, Asian or minority ethnicities (BAME). We assessed whether being from BAME is independently associated with mortality in end-stage kidney disease (ESKD) patients with COVID-19.

Methods: Prospective observational study in a single UK renal center.

Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.

Background: Immune thrombocytopenic purpura (ITP) is primarily characterized by immune-mediated destruction of platelets in circulation. Major treatment options range from careful observation, steroids, immunosuppressive medications, immunoglobulins to splenectomy. Interestingly and rarely, ITP has also been reported after solid organ transplantation in patients receiving immunosuppressive medications.